Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
98
NCT04450160
Trial of AEO in New Glioblastoma (GBM)
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2020
Completion: Sep 30, 2022
NCT04290897
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
Role: Collaborator
Start: Sep 29, 2021
Completion: Nov 12, 2024